Scancell【SCLP】銘柄情報

Scancell Hldgs Plc (SCLP) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

21.75

( -3.76% )

買値

21.50

売値

22.00

出来高

1,925,171

21.40 日の範囲 22.55

7.90 52 週間の範囲 29.50

時価総額

225.717M

前日終値

22.60

始値

22.50

時刻

2251

21.9

(O)

最終取引時間

財務取引量

419,689p

VWAP

21.8001

平均取引量 (3 か月)

2,041,588p

発行済株式数

1,037,781,403

配当利回り

PER

-32.21

1 株当たり利益 (EPS)

-0.01

歳入

4.71M

純利益

-5.51M

Scancell Holdings plc, a clinical stage biopharmaceutical company, discovers and develops of immunotherapies for the treatment of cancer in the United Kingdom. Its product candidates include SCIB1/iSCIB1+ that is in Phase II for the treatment of melanoma; and SC134, an antibody for the treatment of ... Scancell Holdings plc, a clinical stage biopharmaceutical company, discovers and develops of immunotherapies for the treatment of cancer in the United Kingdom. Its product candidates include SCIB1/iSCIB1+ that is in Phase II for the treatment of melanoma; and SC134, an antibody for the treatment of small cell lung cancer. It also develops Modi-1, an active peptide immunotherapy that is in phase II clinical trials for the treatment of solid tumors, including renal, head and neck, ovarian and triple negative breast cancers; and Modi-2, which targets stress-induced post translational modifications, such as homocittrullination. In addition, the company provides GlyMab platform that generates various affinity tumour specific monoclonal antibodies (mAb) targeting glycans that are over-expressed on cancer cells; and AvidiMab, which romotes receptor clustering thereby improving immune signalling. Scancell Holdings plc was founded in 1996 and is based in Oxford, the United Kingdom. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

www.scancell.co.uk

本社

Oxford, United Kingdom

設立

1996

Scancell Hldgs Plc is listed in the Healthcare sector of the ロンドン証券取引所 with ticker SCLP. The last closing price for Scancell was 22.60p. Over the last year, Scancell shares have traded in a share price range of 7.90p to 29.50p.

Scancell currently has 1,037,781,403 shares in issue. The market capitalisation of Scancell is £225.72 million. Scancell has a price to earnings ratio (PE ratio) of -32.21.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-2.25	-9.375	24	24.75	21.4	1166166	23.57110947	DE
4	4.75	27.9411764706	17	29.5	17	3422148	22.81177415	DE
12	9	70.5882352941	12.75	29.5	11	2093201	18.59561611	DE
26	11.8	118.592964824	9.95	29.5	9.75	1777107	15.64684295	DE
52	11.25	107.142857143	10.5	29.5	7.9	1335492	13.60489051	DE
156	6.875	46.218487395	14.875	29.5	7.25	955530	12.7913704	DE
260	0.75	3.57142857143	21	29.5	7.25	921469	14.94502545	DE